Terminated NA INTERVENTIONAL 1-arm NCT01819142

AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers

A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in Stage II-IV Pressure Ulcers

Sponsor: Cytomedix

Conditions Pressure Ulcer

Interventions AutoloGel

Updated 5 times since 2017 Last updated: Oct 19, 2016 Started: Apr 30, 2013 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Protocol study design was re-worked in collaboration with CMS

Other terminated trials from Cytomedix

More terminations from Cytomedix

Other Pressure Ulcer trials with similar outcome

Browse all Pressure Ulcer trials

Listed as NCT01819142, this NA trial focuses on Pressure Ulcer and remains terminated or withdrawn. Sponsored by Cytomedix, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cytomedix

Data source: Cytomedix

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pascagaula, United States